Navigation Links
NeoStem's CEO Letter to Shareholders
Date:1/3/2012

NEW YORK, Jan. 3, 2012 /PRNewswire/ --

Dear NeoStem Shareholders,

We would like to take a moment to both look back at 2011 - a transformative year for NeoStem (NYSE Amex: NBS) – and to look ahead to near term catalysts that we expect to move the company forward in 2012 and beyond.

  • We have closed two acquisitions - Progenitor Cell Therapy, LLC ("PCT") and Amorcyte, LLC ("Amorcyte").
  • We believe our therapeutic product development team is very close to accomplishing its aggressive goal of getting a first patient enrolled in our AMR-001 Phase 2 clinical trial for the treatment of AMI with the clinical sites beginning to open.  This brings us closer to achieving our goal of enrollment of the targeted 160 patients in the study over the next year or so with first data follow-up six months after the last patient is enrolled (roughly mid-2013).
  • Our cell therapy manufacturing business is growing and client satisfaction confirms our belief and excitement that we have unique skills and people (expertise, quality and work ethic) to serve as a platform to be a global leader in the cell therapy space.
  • We raised $16.5 million in gross proceeds in 2011 for working capital, including research and development of our cell therapeutic candidates.
  • We received awards of over $1.7 million in Department of Defense funding for development of our VSELTM Technology to treat osteoporosis and $245,176 from the National Institutes of Health (NIH) with Excell Therapeutics to progress our T regulatory program in Lupus. 
  • We co-hosted a spectacular international conference in partnership with the Vatican's Pontifical Council for Culture on Adult Stem Cells: Science and the Future of Man and Culture, moving forward the public discussion of adult stem cells and adult stem cell research.
  • Our cord blood banking
    '/>"/>

  • SOURCE NeoStem, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xian Qinba Xintong Medical Ltd.
    2. CTI Receives NASDAQ Letter
    3. Synvista Therapeutics Posts Letter to Stockholders on Web Site
    4. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
    5. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
    6. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
    7. Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
    8. Cell Therapeutics to Request a Hearing With NASDAQ Following Receipt of Staff Determination Letter
    9. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
    10. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
    11. deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/17/2013)... available in German . ... the naked eye, you can see which branch a bird ... of branches through the telephoto lens for high-magnification images requires ... are looking to study proteins, the active biomolecules of cells. ... for Molecular Systems Biology, and her colleagues have now come ...
    (Date:5/17/2013)... 2013 New interactive learning ... thought leaders of the medical device industry at ... and expo, from June 18-20 in ... http://photos.prnewswire.com/prnh/20130517/613829 ) , These all-new ... professionals practical presentations and implementable solutions on the ...
    (Date:5/17/2013)...  Insero Health, Inc., a company developing natural compounds ... neurological disorders, is today reporting top-line results from a ... patients with drug-resistant epilepsy.  The data are being presented ... meeting by Dr. Steven Schachter , ... Advisory Board.  In this study, INS001 appeared safe and ...
    (Date:5/17/2013)... 2013 Rust removal is one of home ... items could be damaged. To help rust contractors make it ... no-scrubbing rust remover it called Rusterizer. It announced ... 10% discount. , My Cleaning Products explained that rust could ... by staining them. The first one, it said, happens ...
    Breaking Biology Technology:Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2
    ... United Therapeutics Corporation (NASDAQ: UTHR ) (the ... market and other conditions, $210 million aggregate principal amount of ... accordance with Rule 144A under the Securities Act of 1933, ... grant to the initial purchaser of the notes an option ...
    ... 2011 PAT and QbD remains a field that ... released by Pharma IQ across the PAT and QbD community it ... they were not implementing PAT/QbD was due to a lack of ... once again opens its doors to industry specialists from the PAT ...
    ... Reportlinker.com announces that a new market research ... Nanobiotechnology: Applications and Global Markets ... The total market for nanobiotechnology products ... growing at a compound annual growth rate ...
    Cached Biology Technology:United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program 2United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program 3United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program 4Establishing the Correct QbD Strategies and Tools Early in the Development Process is Key to Ensuring we Have Robust Quality Products Downstream 2Nanobiotechnology: Applications and Global Markets 2Nanobiotechnology: Applications and Global Markets 3Nanobiotechnology: Applications and Global Markets 4Nanobiotechnology: Applications and Global Markets 5Nanobiotechnology: Applications and Global Markets 6Nanobiotechnology: Applications and Global Markets 7Nanobiotechnology: Applications and Global Markets 8Nanobiotechnology: Applications and Global Markets 9Nanobiotechnology: Applications and Global Markets 10Nanobiotechnology: Applications and Global Markets 11Nanobiotechnology: Applications and Global Markets 12Nanobiotechnology: Applications and Global Markets 13
    (Date:5/17/2013)... The Federation of American Societies for Experimental Biology ... Institutes of Health (NIH) funding trends highlighting the devastating ... critical research. The FASEB analysis follows a May 15th ... MD, PhD, who testified that the $1.6 billion cut ... is "having a substantial impact on the scientific community." ...
    (Date:5/16/2013)... 17, 2013) Illustrating a commitment to the ... Gastroenterological Association (AGA) Research Foundation has announced the ... Fellowship Award recipients. Supported by the National Institute ... this new award helps underrepresented minority students to ... nutrition research. , "By establishing this new award, ...
    (Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) ... The Society for Developmental Biology (SDB) 72nd Annual ... These awards are meant to promote the entry ... into the mainstream of the basic science community ... at the SDB 2013 Annual Meeting. , Awards ...
    Breaking Biology News(10 mins):Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
    ... anti-aging technologies may extend human lifespans at an unprecedented ... economic challenges, says biologist Shripad Tuljapurkar of Stanford University. ... have major implications for the global community in the ... of Population Studies, will give a talk Feb. 17 ...
    ... Mayr's theory of genetic revolution , introduced in 1954, ... detractors. , Mayr believed that genes interacted with one ... to an interaction of natural selection with genetic drift ... change. , Detractors of the theory object to what ...
    ... range of diseases in several animal species has been found ... was found most often in the blood of individuals with ... exposure. , A study on these findings was published Wednesday ... by scientists from Oregon State University, the Center for Pediatric ...
    Cached Biology News:World faces challenge as life expectancies lengthen, scientist says 2World faces challenge as life expectancies lengthen, scientist says 3World faces challenge as life expectancies lengthen, scientist says 4Ernst Mayr's theory illustrated in genetic epidemiology studies 2Ernst Mayr's theory illustrated in genetic epidemiology studies 3Ernst Mayr's theory illustrated in genetic epidemiology studies 4Ocean virus identified in human blood samples 2Ocean virus identified in human blood samples 3Ocean virus identified in human blood samples 4
    ... 5 gasket slides/kit Gasket slide kit (1x ... or Gasket slide ... of disposable gasket slides offered in either 11K or ... formats. The gaskets are carefully fabricated and batch ...
    ... General description: self locking design ... is a new product number, created ... If showing no availability yet, please ... (Z71,348-1) or contact customer service for ...
    ... The Arabidopsis 2 Oligo Microarray Kit (V2), 22K ... stages, and stress response. Each microarray contains content ... The Institute for Genomic Research (TIGR) and represents ... 5 standard 1 x 3? glass slides ...
    ... costs of poor quality running into ... organizations are under increasing pressure to ... production, the microscopic distribution of ingredients ... parameters such as dissolution, stability, bio-availability ...
    Biology Products: